NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

Autor: Pascual-Figal D., Wachter R., Senni M., Bao W., Noe A., Schwende H., Butylin D., Prescott M. F., Gniot J., Mozheiko M., Lelonek M., Dominguez A. R., Horacek T., Garcia del Rio E., Kobalava Z., Mueller C. E., Cavusoglu Y., Straburzynska-Migaj E., Slanina M., vom Dahl J., Ryding A., Moriarty A., Robles M. B., Villota J. N., Quintana A. G., Nitschke T., Garcia Pinilla J. M., Bonet L. A., Chaaban S., Filali zaatari S., Spinar J., Musial W., Abdelbaki K., Belohlavek J., Fehske W., Bott M. C., Hoegalmen G., Leiro M. C., Ozcan I. T., Mullens W., Kryza R., Al-Ani R., Loboz-Grudzien K., Ermoshkina L., Hojerova S., Fernandez A. A., Spinarova L., Lapp H., Bulut E., Almeida F., Vishnevsky A., Belicova M., Witte K., Wong K., Droogne W., Delforge M., Peterka M., Olbrich H. -G., Carugo S., Nessler J., McGill T. H., Huegl B., Akin I., Moreira I., Baglikov A., Thambyrajah J., Hayes C., Barrionuevo M. R., Yigit Z., Kaya H., Klimsa Z., Radvan M., Kadel C., Landmesser U., Di Tano G., Lisik M. B., Fonseca C., Oliveira L., Marques I., Santos L. M., Lenner E., Letavay P., Bueno M. G., Mota P., Wong A., Bailey K., Foley P., Hasbani E., Virani S., Massih T. A., Al-Saif S., Taborsky M., Kaislerova M., Motovska Z., Cohen A. A., Logeart D., Endemann D., Ferreira D., Brito D., Kycina P., Bollano E., Basilio E. G., Rubio L. F., Aguado M. G., Schiavi L. B., Zivano D. F., Lonn E., El Sayed A., Pouleur A. -C., Heyse A., Schee A., Polasek R., Houra M., Tribouilloy C., Seronde M. F., Galinier M., Noutsias M., Schwimmbeck P., Voigt I., Westermann D., Pulignano G., Vegsundvaag J., Da Silva Antunes J. A., Monteiro P., Stevlik J., Goncalvesova E., Hulkoova B., Castro Fernandez A. J., Davies C., Squire I., Meyer P., Sheppard R., Sahin T., Sochor K., De Geeter G., Schmeisser A., Weil J., Soares A. O., Bulashova O. V., Oshurkov A., Sunderland S. J., Glover J., Exequiel T., Decoulx E., Meyer S., Muenzel T., Frioes F., Arbolishvili G., Tokarcikova A., Karlstrom P., Trullas Vila J. C., Perez G. P., Sankaranarayanan R., Nageh T., Alasia D. C., Refaat M., Demirkan B., Al-Buraiki J., Karabsheh S.

Objectives: This study examined the effects of sacubitril/valsartan on N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels and determined patient characteristics associated with favorable NT-proBNP reduction response. Background: NT-proBNP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::04c2404eebb56e42eb37d0e482ea15d5
http://hdl.handle.net/10281/372963

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction.

Autor: Zhu, Xiaogang¹ (AUTHOR) shougun@126.com, Li, Xialing¹ (AUTHOR), Zhu, Lingxuan² (AUTHOR), Tong, Zichuan¹ (AUTHOR), Xu, Xiuying³ (AUTHOR), Menezes-Rodrigues, Francisco Sandro (AUTHOR) sandro.rodrigues@unifesp.br

Publikováno v: Cardiovascular Therapeutics. 11/4/2024, Vol. 2024, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Atrial Strain and Strain Rate in a General Population: Do These Measures Improve the Assessment of Elevated NT‐proBNP Levels?

Autor: Rösner, Assami^1,2 (AUTHOR) assami.rosner@unn.no, Kornev, Mikhail^1,2 (AUTHOR), Caglayan, Hatice Akay^1,2 (AUTHOR), Queiros, Sandro^3,4 (AUTHOR), Malyutina, Sofia^5,6 (AUTHOR), Ryabikov, Andrew^5,6 (AUTHOR), Kudryavtsev, Alexander V.^7,8 (AUTHOR), Schirmer, Henrik^9,10 (AUTHOR), Caminiti, Giuseppe (AUTHOR)

Publikováno v: Cardiology Research & Practice. 8/26/2024, Vol. 2024, p1-12. 12p.